Organon Secures FDA Approval for Poherdy, First Pertuzumab Biosimilar in the U.S.

Organon and Shanghai Henlius Biotech have received FDA approval for Poherdy, the first pertuzumab biosimilar in the US. Organon operates in the healthcare sector, focusing on women's health, biosimilars, and established brands. Despite recent product approval, the company faces financial challenges, including declining margins and a high debt-to-equity ratio.